PRSS3 and prostate carcinoma: Furthermore, using a murine model of prostate cancer cells transplanted into the prostate (orthotopic model), the Radisky group showed that primary tumor progression and metastasis formation were markedly decreased in mice with transplanted mesotrypsin‐silenced cancerous cells vs. mice with transplanted non‐silenced cancerous cells [9].